Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020

• Main Authors: Xinning Tong (Author), Xue Li (Author), Nicole L. Pratt (Author), Jodie B. Hillen (Author), Tyman Stanford (Author), Michael Ward (Author), Elizabeth E. Roughead (Author), Edward Chia-Cheng Lai (Author), Ju-Young Shin (Author), Franco W.T. Cheng (Author), Kuan Peng (Author), Chak Sing Lau (Author), Wai Keung Leung (Author), Ian C.K. Wong (Author)
• Format: Book
• Published: Elsevier, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Monoclonal antibody (mAb) and Fc-fusion protein (FcP) are highly effective therapeutic biologics. We aimed to analyse consumption and expenditure trends in 14 Asia-Pacific countries/regions (APAC) and three benchmark countries (the UK, Canada, and the US). Methods: We analysed 4...